GB0206505D0 - Pharmaceutical combination - Google Patents

Pharmaceutical combination

Info

Publication number
GB0206505D0
GB0206505D0 GB0206505A GB0206505A GB0206505D0 GB 0206505 D0 GB0206505 D0 GB 0206505D0 GB 0206505 A GB0206505 A GB 0206505A GB 0206505 A GB0206505 A GB 0206505A GB 0206505 D0 GB0206505 D0 GB 0206505D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical combination
pharmaceutical
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0206505A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euroceltique SA
Original Assignee
Euroceltique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroceltique SA filed Critical Euroceltique SA
Priority to GB0206505A priority Critical patent/GB0206505D0/en
Publication of GB0206505D0 publication Critical patent/GB0206505D0/en
Application status is Ceased legal-status Critical

Links

GB0206505A 2002-03-19 2002-03-19 Pharmaceutical combination Ceased GB0206505D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0206505A GB0206505D0 (en) 2002-03-19 2002-03-19 Pharmaceutical combination

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0206505A GB0206505D0 (en) 2002-03-19 2002-03-19 Pharmaceutical combination
PCT/GB2003/001182 WO2003080183A1 (en) 2002-03-19 2003-03-19 Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids
AU2003226496A AU2003226496A1 (en) 2002-03-19 2003-03-19 Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids

Publications (1)

Publication Number Publication Date
GB0206505D0 true GB0206505D0 (en) 2002-05-01

Family

ID=9933308

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0206505A Ceased GB0206505D0 (en) 2002-03-19 2002-03-19 Pharmaceutical combination

Country Status (3)

Country Link
AU (1) AU2003226496A1 (en)
GB (1) GB0206505D0 (en)
WO (1) WO2003080183A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110052723A1 (en) * 2008-02-18 2011-03-03 Baeyens-Cabrera Jose Manuel Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
CN103860551A (en) * 2012-12-10 2014-06-18 鲁南制药集团股份有限公司 Pharmaceutical composition containing etodolac and tramadol hydrochloride and application thereof
MX2016007285A (en) 2013-12-17 2016-08-04 Esteve Labor Dr SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69527617D1 (en) * 1994-04-12 2002-09-05 Arakis Ltd A process for the resolution of racemic etodolac using glucamine derivatives
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
RS49982B (en) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
FR2770131A1 (en) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Analgesic combinations of a cyclooxygenase-2 inhibitor and acetaminophen or an opiate having synergistic activity
US6007841A (en) * 1998-03-13 1999-12-28 Algos Pharmaceutical Corporation Analgesic composition and method for treating pain
AU1398899A (en) * 1998-11-12 2000-06-05 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
WO2001019349A2 (en) * 1999-09-10 2001-03-22 Ranbaxy Laboratories Limited Extended release formulation of etodolac
SI2092936T1 (en) * 2000-02-08 2013-07-31 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
US20020187995A1 (en) * 2001-05-01 2002-12-12 Fitzgerald Desmond Joseph Methods for use in modifying the perception of pain

Also Published As

Publication number Publication date
WO2003080183A1 (en) 2003-10-02
AU2003226496A1 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
DE60328009D1 (en) Mobil-account-authentifikationsdienst
DE60316175D1 (en) Thrombolysekatheter
DE60333260D1 (en) Histone-deacetylase-inhibitoren
DE60334205D1 (en) Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
DE60311980D1 (en) Histondeacetylase-hemmer
DE60318193D1 (en) Phenethanolaminderivate
DE60336807D1 (en) Hepatitis-c-virus-hemmer
DE60332733D1 (en) Thorax-aortenaneurysma-stentimplantat
DE60325193D1 (en) Misch-stent
DE60301491D1 (en) Acc-hemmer
DE60331670D1 (en) Heterocyclocarboxamidderivate
DE60325365D1 (en) Clip-operationsgerät
DE50311874D1 (en) Spirocyclische cyclohexan-derivate
DE60329700D1 (en) Glycoproteinsynthese
DE60321141D1 (en) Cathepsin-cystein-protease-hemmer
DE60329001D1 (en) 8-hydroxychinolinderivate
DE60311794D1 (en) Signalsynthese
DE50311977D1 (en) Multimetalloxidmassen
DE50312422D1 (en) Aryloxime
DE60331089D1 (en) Intervertebralprothese
DE50310118D1 (en) Ationseinrichtung
DE50312189D1 (en) Nanoimprint-resist
DE60315313D1 (en) Polytrimethylenetherester
DE60315044D1 (en) Wellgetriebemotor
DE60319515D1 (en) Delta-sigma-modulator

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)